Company Profile
Rivalry Capital is a private equity firm dedicated to investing in emerging and lower middle market companies primarily within the healthcare and technology sectors. The firm leverages a disciplined, system-based investment approach that combines applied mathematics, artificial intelligence, operational expertise, and clinical knowledge to identify and accelerate growth in transformative healthcare businesses. Their mission is to back bold ideas and visionary leaders who are reshaping how healthcare works, addressing systemic inefficiencies and fragmentation in the healthcare ecosystem.
The founding team includes Jim Chandler CFA, Matt Young MBA, Robert Moghim MD, and Kian Modanlou MD, who collectively bring experience from a successful track record of over $450 million in cumulative exits. Rivalry Capital aims to partner with exceptional leaders and companies delivering real improvements across the entire care ecosystem, focusing on scalable alternatives to antiquated healthcare systems and processes.
The firm's investment thesis emphasizes transparency, efficiency, and clinical relevance, aspiring to support growth-stage contenders that integrate technology, clinical expertise, and operational leverage to deliver scalable transformations within the healthcare sector.
News & Signals (0)
No linked news activity found for this company.